Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Union Commerce Minister engages pharma stakeholders to address exporter challenges

MD Bureau18 Oct 2024 9:30 AM IST

During the meeting, the focus was laid on identifying key hurdles that pharmaceutical exporters encounter.

Granules Pharma incorporates wholly owned subsidiary in Canada

Granules India appoints Ramraj Rangarajulu as President, Head of Formulations Operations

MD Bureau17 Oct 2024 6:17 PM IST

New Delhi: Granules India Limited has recently announced the appointment of Ramraj Rangarajulu as President and Head of Formulations Operations,...

Wockhardt to exit US generic pharmaceutical segment

Wockhardt seeks DCGI nod to market Aspart insulin injection

MD Bureau17 Oct 2024 4:00 PM IST

Wockhardt's Aspart insulin injection is an indigenously developed product, underscoring the company's end to end capabilities in research and...

Novavax faces setback as USFDA halts COVID-Flu vaccine trial over nerve damage report

MD Bureau17 Oct 2024 3:13 PM IST

Novavax said a participant enrolled in a mid stage study of the combination vaccine last month reported symptoms of motor neuropathy.

CDSCO Panel Directs Mankind Pharma to Conduct Phase I Trial of Sintilimab Before Phase III Launch

Mankind Pharma secures Rs 50 billion funding for Bharat Serums acquisition

MD Bureau17 Oct 2024 2:54 PM IST

In July, Mankind said it would acquire BSV for an enterprise value of around 136.30 billion rupees, with the majority of the deal being funded via...

Govt partnering with IMDRF, ISO, WHO, SEARN to harmonize regulatory requirements, says Union MoS Health

MD Bureau17 Oct 2024 10:00 AM IST

Delhi: Union Minister of State for Health and Family Welfare, Anupriya Singh Patel, has said that the Government is collaborating globally with...

Abbott Volt Pulsed Field Ablation System bags USFDA approval for atrial fibrillation

Abbott's review plea challenging NPPA ceiling price fixation of 18 formulations rejected by DoP

Farhat Nasim16 Oct 2024 4:59 PM IST

New Delhi: The Department of Pharmaceuticals (DoP) has dismissed two review applications filed by Abbott Healthcare Private Limited (AHPL) challenging...

Strides Pharma Science: Nandini Matiyani joins as Executive VP - Human Resources

Strides Pharma arm raises Rs 801 crore in pre-listing round

MD Bureau16 Oct 2024 4:57 PM IST

OneSource Specialty Pharma, the CDMO arm of the company, has received confirmed capital infusion commitment from investors

GSK alleges patent infringement by Moderna in development of COVID19, RSV vaccines, files lawsuit

MD Bureau16 Oct 2024 3:51 PM IST

London: British drugmaker GlaxoSmithKline (GSK) sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of violating...

Lupin Expands GLP-1 Portfolio with Galenicum Semaglutide Deal

Lupin launches first generic of Pred Forte in US with 180-day exclusivity

MD Bureau16 Oct 2024 1:39 PM IST

Pred Forte had estimated annual sales of USD 198 million in the U.S. (IQVIA MAT August 2024)

Johnson & Johnson ordered to pay Rs 128 crore to man claiming its baby powder caused his cancer

MD Bureau16 Oct 2024 1:20 PM IST

Plaintiff Evan Plotkin sued the company in 2021 soon after his diagnosis, saying he was sickened by inhaling JnJ's baby powder.

Fifty percent of global vaccine doses produced by India: Union Health Secretary

MD Bureau16 Oct 2024 10:15 AM IST

Punya said that India has emerged as a global leader in pharmaceuticals, being the third largest producer and a key supplier of generic medicines.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok